Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Prepaid Assets (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Prepaid Assets for 4 consecutive years, with $15.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 26.42% to $15.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.4 million, a 26.42% decrease, with the full-year FY2025 number at $15.4 million, down 26.42% from a year prior.
  • Prepaid Assets was $15.4 million for Q4 2025 at Phathom Pharmaceuticals, up from $13.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $20.9 million in Q4 2024 to a low of $975000.0 in Q3 2022.
  • A 4-year average of $11.3 million and a median of $13.0 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 1226.97% in 2023, then fell 26.42% in 2025.
  • Phathom Pharmaceuticals' Prepaid Assets stood at $5.1 million in 2022, then soared by 157.34% to $13.2 million in 2023, then soared by 58.15% to $20.9 million in 2024, then dropped by 26.42% to $15.4 million in 2025.
  • Per Business Quant, the three most recent readings for PHAT's Prepaid Assets are $15.4 million (Q4 2025), $13.2 million (Q3 2025), and $14.6 million (Q2 2025).